BTK and B-cell chronic lymphocytic leukemia: In CLL, the BCR is constitutively active through ligand-dependent and independent mechanisms, causing constitutive BTK signaling activation, which confers a survival and proliferation advantage to the neoplastic cells (Figure 1) [88].